Charles River Laboratories to Present at William Blair and Jefferies Conferences — Neutral
CRL Business Wire — June 02, 2025WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Present at William Blair and Jefferies Conferences.

BlueLinx Announces Expansion of Distribution Partnership with LP Building Solutions — Neutral
BXC LPX Business Wire — June 02, 2025ATLANTA--(BUSINESS WIRE)--BlueLinx Holdings Inc. (NYSE: BXC), a leading U.S. wholesale distributor of building products, and Louisiana-Pacific Corporation (LP Building Solutions, NYSE: LPX), a leading manufacturer of engineered wood building products, are pleased to announce the expansion of their distribution partnership to Springfield, Missouri. The expanded collaboration will include LP's renowned Siding Solutions brands and prefinished solutions, namely LP® SmartSide® Trim & Siding and.

Thermo Fisher Scientific Unveils Next-generation Mass Spectrometers at ASMS 2025 to Revolutionize Biopharma Applications and Omics Research — Neutral
TMO Business Wire — June 02, 2025WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the launch of the Thermo Scientific™ Orbitrap™ Astral™ Zoom mass spectrometer (MS) and the Thermo Scientific™ Orbitrap™ Excedion™ Pro mass spectrometer (MS) to help push the boundaries of scientific discovery. Delivering unrivaled analytical performance and speed, the instruments are designed to uncover complex biological processes that could lead to advancements in p.

Revvity Introduces New IVD Reference Standards for Monitoring Oncology Diagnostic Testing Workflows — Neutral
RVTY Business Wire — June 02, 2025WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced the launch of three Mimix™ reference standards for IVD use, designed for monitoring of next-generation sequencing (NGS) or droplet digital polymerase chain reacting (ddPCR) assays designed to detect somatic mutations in genomic DNA (gDNA) from human samples for IVD use. These cell line-derived reference standards have undergone appropriate design controls to meet U.S. Food and Drug Administration (FDA) regulatory requi.

Scholar Rock Appoints Rebecca McLeod Chief Brand Officer and U.S. General Manager — Neutral
SRRK Business Wire — June 02, 2025CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for patients with spinal muscular atrophy (SMA) and other severe and debilitating neuromuscular diseases, today announced that Rebecca McLeod has been appointed to the newly created role of Chief Brand Officer and U.S. General Manager. In this role, she will be responsible for leading the anticipated U.S. commercial launch of apitegromab fo.

Oportun Issues Letter to Stockholders and Mails Definitive Proxy Materials — Neutral
OPRT GlobeNewsWire — June 02, 2025Highlights strong momentum in driving profitable growth and delivering stockholder value Urges stockholders to vote “ FOR ” Oportun's two highly qualified nominees – Raul Vazquez and Carlos Minetti – on the GREEN proxy card Launches VoteForOportun.com , providing additional information for stockholders SAN CARLOS, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- Oportun (Nasdaq: OPRT), a mission-driven financial services company, today issued a letter to stockholders detailing the progress Oportun's experienced management team and Board of Directors have made in driving financial and operational performance.

Lilly presents first clinical data for its investigational, next-generation FRα targeting ADC in platinum-resistant ovarian cancer at the 2025 ASCO Annual Meeting — Neutral
LLY PRNewsWire — June 02, 2025INDIANAPOLIS , June 2, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced new Phase 1 data showing that its folate receptor alpha (FRα) antibody-drug conjugate (ADC) (LY4170156) demonstrated an encouraging safety profile and anti-tumor activity across dose and FRα expression levels in women with heavily pre-treated platinum-resistant ovarian cancer, including patients previously treated with mirvetuximab soravtansine. A preliminary overall objective response rate (ORR) of 55% was observed at the potential recommended Phase 2 dose of 4 mg/kg.

PriceSmart Announces Earnings Release and Conference Call Details for the Third Quarter of Fiscal 2025 and Plans for Sixth Warehouse Club in the Dominican Republic — Neutral
PSMT PRNewsWire — June 02, 2025SAN DIEGO , June 2, 2025 /PRNewswire/ -- PriceSmart, Inc. ("PriceSmart" or the "Company") (NASDAQ: PSMT) plans to release financial results for the third quarter of fiscal year 2025 on Thursday, July 10, 2025, after the market closes. PriceSmart management will host a conference call at 12:00 p.m.

PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer — Neutral
GEHC LNTH PRNewsWire — June 02, 2025BOCA RATON, Fla. , June 2, 2025 /PRNewswire/ -- PharmaLogic Holdings Corp.

WhiteFiber Inc., Bit Digital's AI Unit, acquires ~1,000,000 square foot North Carolina Industrial Property to Support up to 200 MW HPC Data Center Campus — Neutral
BTBT PRNewsWire — June 02, 2025NEW YORK , June 2, 2025 /PRNewswire/ -- WhiteFiber Inc., the wholly-owned HPC subsidiary of Bit Digital, Inc. (Nasdaq: BTBT) ("Bit Digital" or the "Company"), announced today that it has completed the acquisition of a 96-acre, ~1 million square foot industrial property in Madison, North Carolina. The Company will retrofit the facility into a flagship AI data center campus ("Facility").

Viatris Announces Positive Top-Line Results from Phase 3 LYNX-2 Trial of MR-142 in Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-Contrast Conditions — Neutral
VTRS PRNewsWire — June 02, 2025MR-142 Achieved Primary Endpoint of ≥15-letter (≥3-line) Gain in Mesopic Low Contrast Distance Visual Acuity in Comparison to Placebo Results Showed Patient-Reported Functional Benefit in Treating Significant Chronic Night Driving Impairment in Keratorefractive Patients With Reduced Mesopic Vision, a Condition With No Current FDA-Approved Therapies No Evidence of Tachyphylaxis Was Observed In This Study Over The 6-Week Period Study Was Conducted Under FDA Special Protocol Assessment And Fast-Track Designation PITTSBURGH , June 2, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced positive top-line results from LYNX-2, a pivotal Phase 3 trial evaluating MR-142 (phentolamine ophthalmic …

TEN Holdings Announces Early Adopter Program for New SaaS Product, Ten Events Pro — Neutral
XHLD PRNewsWire — June 02, 2025LANGHORNE, Pa. , June 2, 2025 /PRNewswire/ -- TEN Holdings, Inc. (NASDAQ: XHLD) ("TEN Holdings" or the "Company"), a provider of event planning, production, and broadcasting services through its subsidiary, Ten Events, Inc., a Pennsyvania corporation ("Ten Events"), today announced the launch of an Early Adopter Program for its software-as-a-service ("SaaS") product, Ten Events Pro ("Ten Pro").

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against UnitedHealth Group Incorporated (NYSE: UNH) — Neutral
UNH Accesswire — June 02, 2025NEW YORK, NY / ACCESS Newswire / June 2, 2025 / Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a complaint has been filed in the United States District Court for the Southern District of New York on behalf of investors (the "Class") who purchased or acquired the securities of UnitedHealth Group Incorporated ("UnitedHealth" or the "Company") (NYSE: UNH) between December 3, 2024 and April 16, 2025, inclusive, alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its senior officers (the "Complaint"). Should You Join This Class Action Lawsuit?

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against DoubleVerify Holdings, Inc. (NYSE: DV) — Neutral
DV Accesswire — June 02, 2025NEW YORK, NY / ACCESS Newswire / June 2, 2025 / Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a complaint has been filed in the United States District Court for the Southern District of New York on behalf of investors (the "Class") who purchased or acquired the common stock of DoubleVerify Holdings, Inc. ("DoubleVerify" or the "Company") (NYSE: DV) between November 10, 2023 and February 27, 2025, inclusive, alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its senior officers. (the "Complaint").

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Treace Medical Concepts, Inc. (NASDAQ: TMCI) — Neutral
TMCI Accesswire — June 02, 2025NEW YORK, NY / ACCESS Newswire / June 2, 2025 / Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a complaint has been filed in the United States District Court for the Middle District of Florida on behalf of investors who purchased or acquired the securities of Treace Medical Concepts, Inc. ("Treace Medical" or the "Company") (NASDAQ: TMCI) between May 8, 2023 and May 7, 2024, inclusive, alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its senior officers (the "Complaint"). Should You Join This Class Action Lawsuit?

Wyndham's First-Annual Owner Trends Report Highlights Positive Long-Term Outlook, Vital Role of Brands — Neutral
WH PRNewsWire — June 02, 2025Hotel owners and property developers remain confident in industry's resiliency despite a news cycle dominated by tariffs, inflation, interest rates and more PARSIPPANY, N.J. , June 2, 2025 /PRNewswire/ -- Wyndham Hotels & Resorts today unveiled its first-annual Hotel Owner Trends Report.

Harmonic's cOS Broadband Platform Enables World's First PTP-less Deployment to Fuel Vectra's Network Transformation and Enable Wholesale Fiber and DOCSIS Offerings SAN JOSE, Calif. , June 2, 2025 /PRNewswire/ -- Harmonic (NASDAQ: HLIT) today announced that Vectra, one of the largest internet providers in Poland, has selected Harmonic's industry-leading cOS™ virtualized broadband platform to accelerate its multigigabit broadband service expansion, enable selective migration to deep fiber infrastructure and power its new wholesale fiber and DOCSIS offerings.

Lyntia Networks Accelerates Automation with Oracle Unified Operations — Neutral
ORCL PRNewsWire — June 02, 2025Spanish service provider transforms key processes to enhance business agility and service delivery with Oracle Communications and Optare Solutions AUSTIN, Texas and MADRID , June 2, 2025 /PRNewswire/ -- Lyntia Networks, a leading neutral operator in the wholesale telecom sector, is relying on Oracle solutions to help meet its ambitious growth in the highly competitive infrastructure and connectivity markets. The operator is leveraging the out-of-the-box capabilities of Oracle Communications cloud native solutions to transform its operational support systems (OSS), enabling faster service delivery through automated orchestration processes.

Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer — Neutral
WAT PRNewsWire — June 02, 2025News Summary Up to six-fold increase in performance robustness with StepWave™ XR Ion Guide versus Xevo TQ Absolute.1 Uses up to 50% less power and gas, and occupies up to 50% less bench space than other products in its class.2 Takes the industry-leading sensitivity of Xevo TQ Absolute to new heights, including for PFAS detection and pharma quantitation applications. BALTIMORE and MILFORD, Mass.

Marriott International Celebrates Outstanding 25-Year Leadership in Branded Residences with Around 300 Projects in Open & Pipeline Portfolio — Neutral
MAR PRNewsWire — June 02, 2025Marriott bolsters industry's largest residential portfolio with several signed agreements in desirable destinations around the world. NEW YORK , June 2, 2025 /PRNewswire/ -- Today, Marriott International, Inc. (Nasdaq: MAR), the industry leader in branded residential development, announces signed agreements in: Detroit, Michigan ; Muskoka, Canada; Gulf of Papagayo, Guanacaste, Costa Rica; and Jeddah, Saudi Arabia ; bringing the Marriott Branded Residences total open and pipeline portfolio to around 300 projects.
